Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma

Published:2018-10 Issue:10 Volume:20 Page:939-948
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Nakagawa Shigeki,Okabe Hirohisa,Ouchi Mayuko,Tokunaga Ryuma,Umezaki Naoki,Higashi Takaaki,Kaida Takatoshi,Arima Kota,Kitano Yuki,Kuroki Hideyuki,Mima Kosuke,Nitta Hidetoshi,Imai Katsunori,Hashimoto Daisuke,Yamashita Yo-ichi,Chikamoto Akira,Baba Hideo

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference46 articles.

1. The pathobiology of biliary epithelia;Alpini;Hepatology,2002

2. The pathobiology of biliary epithelia;Roberts;Gastroenterology,1997

3. "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention;Farley;Mayo Clin Proc,1995

4. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development;Kunju;Mod Pathol,2011

5. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells;Kleer;Proc Natl Acad Sci U S A,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ancillary tests for hepatobiliary neoplasms: what we know and what we need to know;Human Pathology;2023-11

2. Tregs are involved in VEGFA/ VASH1-related angiogenesis pathway in ovarian cancer;Translational Oncology;2023-06

3. EZH2 Promotes Cholangiocarcinoma Development and Progression through Histone Methylation and microRNA-Mediated Down-Regulation of Tumor Suppressor Genes;The American Journal of Pathology;2022-12

4. Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses;Life Sciences;2022-11

5. SMYD3 regulates gastric cancer progression and macrophage polarization through EZH2 methylation;Cancer Gene Therapy;2022-09-20